DIRS.INFO The most relevant business & tech news

☆ Why a giant health insurer merger is probably destined to fail
▼ + stars: | 2023-11-30 | by ( ) www.businessinsider.com time to read: +7 min

The giant health insurers Cigna and Humana are reportedly considering a merger. While they offer different kinds of health insurance, the deal is likely to face antitrust scrutiny. Still, Cigna and Humana did toy with a deal way back in 2014 before they pursued deals with other partners. Later, to sidestep antitrust scrutiny, health insurers eyed mergers with other pieces of the healthcare system outside of insurance. Cigna and Humana would face a more skeptical Justice DepartmentAny deal between health insurers the size of Cigna and Humana would have to get past the Justice Department's antitrust enforcers.

Persons: Biden, —, Justice that's, BofA, David Balto, Cigna, That's, Balto, Barak Richman, there's, Matthew Cantor, Constantine Cannon, divestitures aren't, Molina wouldn't, Cantor Organizations: Humana, Service, Reuters, Bloomberg, Street, Department, Justice, Cigna, UnitedHealth Group, Equity, Federal Trade Commission, Justice Department, Express, CVS Health, Aetna, Kindred, Biden Administration, FTC, Duke University Locations: Cigna, Aetna, Delaware

☆ Jim Cramer looks at why Eli Lilly is the 'only drug stock that’s working' right now
▼ + stars: | 2023-11-29 | by ( Paulina Likos | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer releases the Homestretch audio feature in time for the last hour of trading on Wall Street. Elsewhere, Jim Cramer called biopharma stock Eli Lilly (LLY) "the only drug stock that's working" in a competitive health care field. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Stocks, Locker, Mary Dillon's, Eli Lilly, Lilly, bode, Jim, FTC's Lina Khan, Jim Cramer's Organizations: CNBC, Meta, Club, UnitedHealth, FTC, Jim Cramer's Charitable

REUTERS/Andrew Kelly/File Photo Acquire Licensing RightsNov 29 (Reuters) - Cigna (CI.N) and Humana (HUM.N), two of the biggest U.S. health insurers, are in talks for what could be the largest merger announced in 2023, according to a source familiar with the matter. A Humana and Cigna combination would give the merged company the scale to rival UnitedHealth Group (UNH.N) and CVS Health (CVS.N). In July 2016, the Justice Department filed lawsuits against two health insurance mergers on the same day, saying they would lead to less competition and higher prices for Americans. Health insurers have been facing higher medical costs as people return for procedures they had put off during the pandemic. Humana in February said that it would sell its commercial business but keep its Medicare Advantage products.

Persons: Andrew Kelly, Cigna, Cigna's, Aetna, Bill Baer, Andre Barlow of Doyle, Barlow, Mazard, Bernstein, Lance Wilkes, Craig Garthwaite, Manas Mishra, Diane Bartz, Deena Beasley, Caroline Humer, Bill Berkrot Organizations: Humana Inc, REUTERS, Street Journal, UnitedHealth, CVS Health, Humana’s, Medicare, Affordable, Justice Department, Humana, U.S ., Reuters, Northwestern University, Thomson Locations: Queens , New York City, U.S, Cigna, Bengaluru, Washington, Los Angeles

☆ Jeremy Grantham's GMO just launched an actively managed fund focused on high-quality stocks. Its manager shares 7 unique companies he's betting on to deliver high returns.
▼ + stars: | 2023-11-24 | by ( William Edwards | ) www.businessinsider.com time to read: +4 min

The GMO US Quality ETF (QLTY) launched on November 12, and as its name implies, the fund seeks to offer investors exposure to so-called quality stocks through an actively managed approach. This story is available exclusively to Business Insider subscribers. "At GMO, internally we also talk about intrinsic value, which is adjusting for growth and quality," Hancock said. The aerospace business manufactures and re-services airplane engines, and the continued resurgence in global demand for travel following the pandemic bodes well for the business, Hancock said. While the timing of the ETF release is not related to Grantham's call, Hancock said quality stocks are typically more defensive in a recessionary environment.

Persons: Tom Hancock, Hancock, Jeremy Grantham, Grantham Organizations: Business, Microsoft, Apple, Nvidia, Electric, GE

☆ Foot Locker, Teamsters Show Their Drug-Benefit Managers the Door
▼ + stars: | 2023-11-21 | by ( Melanie Evans | ) www.wsj.com time to read: 1 min

Employers and unions are getting fed up with the firms they have used for years to help control their spending on prescription drugs—because their costs keep soaring. Footwear retailer Foot Locker dropped UnitedHealth Group ’s OptumRx drug-benefit manager last year, while a Teamsters fund in Philadelphia recently reupped with its replacement for CVS Health ’s Caremark.

Persons: Locker Organizations: Teamsters, CVS Health Locations: Philadelphia

☆ Will the 'Magnificent Seven' have another good run in 2024? Morgan Stanley's Mike Wilson weighs in
▼ + stars: | 2023-11-20 | by ( Weizhen Tan | ) www.cnbc.com time to read: +4 min

Much of the gains in the S & P 500 this year can be attributed to the "Magnificent Seven" stocks. The S & P 500 has rocketed nearly 19% in the year to date. His 2024 price target for the S & P 500 is 4,500. But, he said, "There's going to be … a very good stock picking opportunity, probably away from those seven [stocks] … where there should be more opportunities in the 493." "In today's volatile interest rate environment, we see this cohort offering a balance of relative performance stability along with attractive growth properties," Morgan Stanley said.

Persons: Mike Wilson, Morgan Stanley, CNBC's, Wilson, they've, —, we're, we've, barbells, Eli Lilly, Morgan Organizations: Apple, Microsoft, Nvidia, Tesla, Morgan, Microsoft Tech, Keysight Financial, Visa, Mastercard Consumer, Marriott International Pharmaceuticals, Walmart, Costco . Utilities, DTE Energy, Exelon Corporation . Energy, ConocoPhillips, Marathon Oil, Valero Energy Locations: U.S, Morgan Stanley Asia, Singapore

Analysts attended earnings calls in the third quarter armed with questions for healthcare and consumer companies about the potential effect on their sales from the growing popularity of these drugs, known as GLP-1 agonists. A Reuters analysis of earnings transcripts for the third quarter showed "GLP-1" or alternatives like "obesity" or "weight-loss medications" were mentioned 256 times across 29 U.S. and European healthcare and consumer companies. That's more than double the mentions for the second quarter, when those phrases came up 127 times. While some consumer companies have talked about factors such as fewer calories being consumed, "these kind of large extrapolations" seem to be a bit of a stretch, said BMO Capital analyst Evan Seigerman. For big pharma manufacturers like Pfizer (PFE.N) and Amgen (AMGN.O), analyst questions were aimed at their obesity drug candidates.

Persons: Lilly, George Frey, Jeff Jonas, it's, Eli Lilly's, John Furner, Mondelez, Eli Lilly, Evan Seigerman, LVMH, Rajesh Kumar, Jonas, Bhanvi Satija, Savyata Mishra, Arpan Varghese, David Gaffen, Shounak Organizations: Novo Nordisk, Pharmacy, REUTERS, Gabelli, Novo, Walmart, Walmart U.S, Hershey, Truist Securities, Krispy, BMO Capital, Danish, pharma, Pfizer, Devices, HSBC, Thomson Locations: Provo , Utah, U.S, United States, Novo, Bengaluru

☆ Legendary value investor's firm launches new fund targeting 'quality' stocks
▼ + stars: | 2023-11-18 | by ( Emily Glass | ) www.cnbc.com time to read: +1 min

Legendary value investor Jeremy Grantham is betting on a special caliber of stocks with his firm's first active ETF: the GMO U.S. Quality ETF. "There's a lot more interest in active ETFs than there was even a few years ago," Hancock told CNBC's "ETF Edge" this week. According to GMO's website, as of November 17th, the ETF's top holdings include Microsoft , UnitedHealth and Johnson & Johnson . "These are battleship companies that are going to remain relevant and important going forward." Shares of UnitedHealth are virtually flat while Johnson & Johnson is down more than 15%.

Persons: Jeremy Grantham, Tom Hancock, Hancock, CNBC's, Johnson Organizations: Quality, Microsoft, Johnson

☆ Jeremy Grantham's GMO launched its first ETF with top portfolio managers. Here's what's in it
▼ + stars: | 2023-11-18 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +2 min

Jeremy Grantham's investment firm is taking its first steps to enter the world of exchange traded funds, debuting a new offering modeled on one of Grantham, Mayo, Van Otterloo's crown jewel mutual funds. The GMO U.S. Quality ETF (QLTY) launched last Wednesday, marking the investment firm's first ETF. The new ETF will be managed by the same team that helms GMO Quality III mutual fund ( GQETX ). The QLTY ETF should see a similar turnover rate of around 20% to what the mutual fund has, he added. Jeremy Grantham, GMO's chief investment strategist, is not directly involved in the new ETF.

Persons: Jeremy, Van, Tom Hancock, Hancock, Jeremy Grantham Organizations: Quality, helms, Morningstar, Microsoft, General Electric Locations: Grantham, Mayo

☆ Falling inflation and rate cuts may be bad for stocks, says Morgan Stanley's Mike Wilson
▼ + stars: | 2023-11-16 | by ( Weizhen Tan | ) www.cnbc.com time to read: +3 min

Contrary to popular perception, falling inflation and interest rate cuts won't necessarily be good for stocks, according to Morgan Stanley's Chief U.S. Equity Strategist Mike Wilson. And falling inflation is bad for stocks because rising prices are what drives earnings, he explained. "Whenever inflation is falling like it is today, it's typically not good for the average stock because it's not good for earnings growth," Wilson explained. The bad news is that "it's pretty clear" that inflation is falling, he said. "So now that inflation is coming down, and they start cutting, just be careful what that means for stocks.

Persons: Morgan, Mike Wilson, Wilson, Morgan Stanley, we've, It's Organizations: Chief U.S, Equity, U.S . Federal Reserve, Morgan, Big Tech, Meta, Facebook, Apple, Netflix, Walmart, Costco . Utilities, DTE Energy, Exelon Corporation . Energy, ConocoPhillips, Marathon Oil, Valero Energy Locations: Chief, Morgan Stanley Asia, Singapore

☆ These are the top 10 holdings of the Mormon Church's $47 billion stock portfolio
▼ + stars: | 2023-11-14 | by ( Matthew Fox | ) www.businessinsider.com time to read: +3 min

The investment arm of the Mormon Church revealed some of its holdings in a 13F filing on Tuesday. These are the top 10 holdings of the Mormon Church's stock portfolio as of September 30. AdvertisementThe Church of Jesus Christ of Latter-day Saints' has an investment portfolio topping $100 billion that includes $47 billion invested in stocks. AdvertisementThe church reports its stock holdings on a quarterly basis, and a recent 13F filing revealed its top holdings as of September 30. These are the Mormon Church's top 10 stocks holdings at the end of the third quarter.

Persons: —, of Jesus Christ, Tesla Brandon Bell, Ethan Miller, Microsoft Satya Nadella, Sean Gallup, Justin Sullivan Organizations: Mormon, Service, of Jesus, SEC, Advisors, Exxon Mobil, Mastercard Reuters, UnitedHealth, Reuters, Nvidia, Microsoft, Getty, Apple

☆ UnitedHealth pushed workers to use algorithms to cut off patient care, Stat investigation finds
▼ + stars: | 2023-11-14 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailUnitedHealth pushed workers to use algorithms to cut off patient care, Stat investigation findsBob Herman, Stat News health care reporter, joins 'Power Lunch' to discuss UnitedHealth using an algorithm to cut off patient care.

Persons: UnitedHealth, Bob Herman Organizations: Stat

☆ Eli Lilly and more: Strategist names 5 stocks set for 'significant' earnings growth
▼ + stars: | 2023-11-10 | by ( Amala Balakrishner | ) www.cnbc.com time to read: +4 min

Rising rates and the possibility of a recession on the horizon have created a "mixed picture" for equity markets, according to one strategist — but several companies can look forward to markedly stronger earnings growth in the next year. "But, if you're looking for significant earnings expansion, I suspect, at a market level, that's probably less likely. The earnings growth rate for the S & P 500 was 3.7% year-on-year – the first quarter with year-on-year growth since the third quarter of 2022, the data showed. "What Eli Lilly is going to do with their weight loss drug is not dependent on whether the rates are 5.2% or 4.8%. "People didn't really talk about [Adobe] — everyone assumed that they were going to be a loser from AI," he said.

Persons: —, they're, Rahul Ghosh, Rowe Price, Ghosh, Eli Lilly, Powell, Software Ghosh, — CNBC's Annika Kim Constantino Organizations: Healthcare Healthcare, UnitedHealth Group, Fellow, Food and Drug Administration, Software, Adobe Creative, Adobe Express

☆ The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock
▼ + stars: | 2023-11-01 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +7 min

"The story is on track, and I think you buy the stock," Jim Cramer said during Wednesday's Morning Meeting . Since its 2023 lows on July 13, Humana stock rallied more than 23% compared with a roughly 7% slide in the S & P 500 over the same stretch. Management's initial commentary on 2024 earnings and Medicare Advantage membership growth — discussed in more detail below — may also have left investors wanting. Humana also expects EPS growth in 2024 to fall on the lower end of its historical long-range 11%-to-15% target. Capital allocation Humana still expects to buy back about $1.5 billion worth of stock in 2023, finance chief Diamond said on the earnings call.

Persons: —, Jim Cramer, they've, UnitedHealth, Humana, Susan Diamond, Diamond, Bruce Broussard, Jim Rechtin, Broussard, Jim Cramer's, Jim Organizations: Medicare, Revenue, Humana, UnitedHealth, CNBC, Inc

☆ Humana shares fall as reaffirmed 2023 profit view disappoints
▼ + stars: | 2023-11-01 | by ( Khushi Mandowara | ) www.reuters.com time to read: +2 min

Signage for Humana Inc. is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. The health insurer stuck to its 2023 adjusted profit target of at least $28.25 per share. As of Sept. 30, 5.9 million members were enrolled in its Medicare Advantage plans, up 14.7% from a year ago. The company raised its forecast for 2023 Medicare Advantage membership for the second time this year, and now expects to add at least 860,000 people. It reported a quarterly adjusted profit of $7.78 per share, beating analysts' estimate of $7.16 per share.

Persons: Andrew Kelly, Humana, Julie Utterback, Utterback, UnitedHealth, Khushi, Milla Nissi Organizations: Humana Inc, REUTERS, Wednesday, Health, Humana, Medicare, Thomson Locations: Queens , New York City, U.S, Bengaluru

Despite a bleak month in October for the stock market, there may be some good news in store for at least four stocks in the Dow Jones Industrial Average . All three major market indexes are in the red this month, with the Dow off by 1.5% since the end of September. But investors may find some relief heading into the year end, since historically November has been a strong month for stocks. Analysts surveyed by LSEG have an average rating of hold on Caterpillar. Based on a consensus price target of $288, Caterpillar offers some 27% upside according to analyst estimates.

Persons: Dow, LSEG, Max, — CNBC's Christopher Hayes Organizations: Dow Jones, Stock, Dow, CNBC, Caterpillar, Analysts, LSEG, Boeing, Max . Insurance, UBS

☆ Here's how much the options market expects Apple shares to move off earnings
▼ + stars: | 2023-10-30 | by ( Michael Khouw | ) www.cnbc.com time to read: +7 min

It's a big week: a Federal Reserve meeting, unemployment numbers and earnings for the biggest company in the S & P 500. The problem is the S & P 500, as a barometer of economic health, much like Pollyanna, skews optimistic by nature of its design. By contrast to the S & P, the R2K tracks smaller, less well-known businesses. In this way a call option will increase in value if the stock price rises through the strike price. In this case the "at-the-money" straddle expiring this coming Friday, November 3rd, is priced at $7.70 or nearly 4.6% of the current stock price.

Persons: Berkshire Hathaway, Tesla, Eli Lilly, ytd, Russell, Friday's Organizations: Reserve, U.S, Apple, Microsoft, Nvidia Locations: Europe, China, U.S, Berkshire

☆ Earnings calls reveal how companies ranging from Coca-Cola to JPMorgan are capitalizing on AI
▼ + stars: | 2023-10-29 | by ( Samantha Subin | ) www.cnbc.com time to read: +4 min

The craze around AI kicked off late last year with the launch of ChatGPT, and dozens of technology companies from Alphabet to Meta Platforms have thrown a hat into the ring . Many companies have utilized AI or machine-learning tools in the past to streamline their businesses. For pharmacy giant Walgreens Boots Alliance and soda maker Coca-Cola , AI is helping improve supply chains, forecast demand and in some cases, predict spending. Centene , UnitedHealth and Elevance Health all highlighted ways they are implementing AI to improve customer offerings. Financials Major financial and banking companies are also finding ways to capitalize on AI to improve efficiencies and their bottom line.

Persons: Gary Guthart, Elevance, UnitedHealth, Erica, Moody's, Andrew Schlossberg, JPMorgan Chase, Jamie Dimon, That's Organizations: CNBC Pro, Consumer, Walgreens Boots Alliance, Supply, Microsoft, Health, Elevance, Bank of America, Google, Mastercard, JPMorgan

☆ Morgan Stanley's stock playbook for this slowing, 'late-cycle' economy
▼ + stars: | 2023-10-25 | by ( Pia Singh | ) www.cnbc.com time to read: +6 min

To play this market, the firm recommended a "barbell" of traditional defensive stocks, some select growth opportunities and late-cycle cyclical names. Take a look below for some of Morgan Stanley's favorite stocks in this slow-growth environment. 1) Traditional Defensives Despite its year-to-date underperformance against the broader market, health care remains Morgan Stanley's preferred defensive sector. Still, popular consumer food companies Yum Brands and McDonald's are considered growth stocks based on their market cap and volatility. 3) Late-Cycle Cyclicals Several energy companies — including Marathon Oil , Valero Energy and ConocoPhillips — can shine in a late-cycle market environment, according to Morgan Stanley.

Persons: Morgan Stanley, Andrew Pauker, Pauker, Morgan Stanley's, Fisher, Dr Pepper, Eli Lilly, Devin McDermott, Ravi Shanker Organizations: Walmart, Fisher, " Beverage, CenterPoint Energy, Costco, Colgate, Palmolive, Yum Brands, UnitedHealth, Marathon Oil, Valero Energy, ConocoPhillips, Swift Transportation, Defense, Northrop Grumman, Howmet Aerospace, Delta Airlines

☆ Our top 5 stocks of October so far as Wall Street rebounds from a September slump
▼ + stars: | 2023-10-17 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +6 min

After a rough September, October has so far been much more kind to stocks and has helped Wall Street cut into some of its third-quarter losses . FL mountain 2023-09-29 Foot Locker's stock performance so far in October. LLY mountain 2023-09-29 Eli Lilly's stock performance so far in October. PANW mountain 2023-09-29 Palo Alto's stock performance so far in October. HUM mountain 2023-09-29 Humana's stock performance so far in October.

Persons: Dow, Locker, Foot, Jim Cramer, Eli Lilly's, Eli Lilly, Jim Cramer's, Jim, Angela Weiss Organizations: Dow Jones, Nasdaq, Nike, Novo Nordisk, Palo Alto Networks, Nvidia, Johnson Controls, Palo Alto, Coterra Energy, Exxon Mobil, Club, Natural Resources, Humana, UnitedHealth, CNBC, New York Stock Exchange, Wall, AFP, Getty Locations: Alto, Israel, U.S, New York City

☆ UBS upgrades this 'core' health care stock, sees nearly 20% upside
▼ + stars: | 2023-10-16 | by ( Brian Evans | ) www.cnbc.com time to read: +1 min

UBS thinks UnitedHealth is an essential portfolio holding trading at a discount. The firm upgraded shares of the health care giant to buy from neutral and raised its target price to $640 from $520. "We believe that the strong Q3 release from UNH is a clearing event that should pave the way for improved valuation for the stock," Rice said. UnitedHealth stock has ticked up nearly 2% in 2023. UNH YTD mountain UNH in 2023 UNH YTD mountain UnitedHealth stock.

Persons: UnitedHealth, AJ Rice, Rice, — CNBC's Michael Bloom Organizations: UBS Locations: UNH

☆ Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Netflix, Colgate, Pfizer, Disney and more
▼ + stars: | 2023-10-16 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

UBS upgrades UnitedHealth to buy from neutral UBS called the stock a "core holding." Jefferies upgrades Pfizer to buy from hold Jefferies said investors should buy the dip in shares of Pfizer. UBS initiates Evolent Health as buy UBS said it sees more upside for the health-care company. Morgan Stanley upgrades Varonis Systems to overweight from equal weight Morgan Stanley said the data security and analytics company has "underappreciated AI tailwinds." UBS upgrades Tal Education to buy from neutral UBS said a turnaround for the education tech company is underway.

Persons: Morgan Stanley, Apple, Jefferies, Goldman Sachs, Horton, Piper Sandler, Tesla, Truist, Stifel Organizations: Apple, JPMorgan, Nvidia, NVIDIA, UBS, UNH, Jefferies, Pfizer, Maplebear Inc, Disney, US Parks, Evolent Health, payors, Varonis, Nice Systems, NICE, Netflix, ISI, Tal Education, RBC, BMO, Energy, Colgate, Palmolive Locations: UNH, U.S

NEW YORK (AP) — Shares fell in Asia as investors braced Monday for an expected invasion by Israel in the Gaza Strip. On Friday, the price of a barrel of benchmark U.S. crude oil jumped $4.78 to settle at $87.69. Early Monday, U.S. crude oil was unchanged while Brent was up 3 cents at $90.92 a barrel. Worries about the war pulled Treasury yields lower, which often happens when investors head for safer investments during times of stress. The yield on the 10-year Treasury fell to 4.63% from 4.70% late Thursday.

Persons: —, Israel, Brent, Korea's Kospi, Australia's, Wells, JPMorgan Chase, Jamie Dimon, Todd Vasos Organizations: Economics, Markets, Nikkei, Nasdaq, Dow, Treasury, United Nations, Federal Reserve, JPMorgan Chase, JPMorgan, UnitedHealth, Wall, Dollar, U.S . Locations: Asia, Israel, Gaza, U.S, Hong Kong, Shanghai, Wells Fargo

☆ These companies reporting in the week ahead have a history of beating estimates and rising
▼ + stars: | 2023-10-15 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

Elsewhere, UnitedHealth Group , a heavyweight in the Dow Jones Industrial Average, gained 2.6% after beating analysts' estimates for earnings and revenue. A number of stocks reporting in the week ahead have a great track record of topping earnings estimates and rallying, according to Bespoke Investment Group data. Citizens stock has slipped more than 34% in 2023. Western Alliance stock, meanwhile, has slipped more than 25% in 2023. WAL YTD mountain Western Alliance stock.

Persons: Goldman Sachs, Needham, Charles Shi, Michael Bloom Organizations: JPMorgan, Wells, UnitedHealth, Dow Jones, Investment, Financial, Citizens, Western Alliance, Lam Research Locations: Wells Fargo

Wall Street's three major indexes opened higher but lost ground after a preliminary reading on U.S. consumer sentiment showed a sharp fall in October. The moves in bonds, equities and oil reflect worries about deteriorating consumer sentiment, the global economy and geopolitical conflict, she added. However, for the week the S&P 500 registered a 0.45% gain for its second weekly advance in a row. The S&P 500 Banks index (.SPXBK) pared gains as the day wore on to close up 0.6% after rising as much as 3.4% to a three-week high. The S&P 500 posted 12 new 52-week highs and 20 new lows; the Nasdaq Composite recorded 28 new highs and 335 new lows.

Persons: Brendan McDermid, Wells, Wall, Dow, Israel, Lauren Goodwin, Goodwin, Patrick Harker, Todd Vasos, Jeff Owen, advancers, Sinéad Carew, Shashwat Chauhan, Ankika Biswas, Shounak Dasgupta, Anil D'Silva, Shinjini Ganguli, Richard Chang Organizations: New York Stock Exchange, REUTERS, JPMorgan, Dow, Nasdaq, The United Nations, Treasury, New York Life Investments, Dow Jones, JPMorgan Chase, Citigroup, Federal Reserve Bank of Philadelphia, BlackRock, Dollar, Boeing, NYSE, Thomson Locations: New York City, U.S, Wells Fargo, Gaza, Israel, BLK.N, Bengaluru

Search resuls for: "UnitedHealth"

25 mentions found